Impact of Transcranial Direct Current Stimulation on the Capacity to Perform Burpees
3 other identifiers
interventional
20
1 country
1
Brief Summary
Introduction and Background: Transcranial direct current stimulation (tDCS) has emerged as a potential intervention to improve physical performance. The primary aim of this study is to investigate the effects of tDCS applied to the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) on performance in a maximal effort task, specifically the No Jump Burpee exercise. Study Design: This study will utilize a double-blind crossover design, where each subject will complete three experimental conditions: a-DLPFC, a-M1, and SHAM. Participants: Twenty healthy male subjects will be recruited for the study. Intervention: Each participant will undergo three conditions in a randomized order: a-DLPFC: tDCS applied to the dorsolateral prefrontal cortex. a-M1: tDCS applied to the primary motor cortex. SHAM: Placebo stimulation. Procedure: Prior to performing the No Jump Burpee exercise to exhaustion, tDCS will be administered at a current of 2 milliampere (mA) for 20 minutes. Measurements: The following variables will be measured during the exercise: Total number of repetitions of the No Jump Burpee exercise. Vastus lateralis muscle oxygen saturation. Heart rate. Subjective perception of exertion (RPE). Data Analysis: Repeated measures ANOVAs will be used to analyze the effects of the different tDCS conditions on the performance outcomes. Ethical Considerations: The study protocol will be reviewed and approved by an appropriate ethics committee. Written informed consent will be obtained from all participants before participation in the study. Objectives: The primary objective is to evaluate the impact of tDCS on physical performance, specifically measuring the total number of repetitions of the No Jump Burpee exercise. Secondary objectives include assessing the changes in muscle oxygen saturation, heart rate, and subjective perception of exertion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedFirst Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedJune 25, 2024
June 1, 2024
2 months
June 13, 2024
June 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of "No Jump Burpees" to Exhaustion
The primary objective of the study is to measure the number of repetitions of the "No Jump Burpee" exercise that participants can perform until exhaustion. This exercise is performed at a cadence of 20 burpees per minute, and exhaustion is determined when the participant can no longer maintain the correct pace or technique.
Measured immediately at the end of each experimental session (DLPFC, M1, SHAM), approximately 5-10 minutes after the start of the test..
Secondary Outcomes (3)
Rating of Perceived Exertion (RPE)
Measured every 20 seconds during exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Muscle Oxygen Saturation in the Vastus Lateralis
Measured continuously at a frequency of 1 Hz during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Heart Rate During Exercise
Measured continuously on a beat-by-beat basis during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Other Outcomes (3)
Mood State Before Exercise
Before each experimental session.
Anxiety Level Before Exercise
Before each experimental session
Sleep Quality on the Night Prior to Exercise
Before each experimental session.
Study Arms (3)
tDCS Targeting the Dorsolateral Prefrontal Cortex (DLPFC)
EXPERIMENTALParticipants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the DLPFC. The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of DLPFC stimulation on performance during a maximal effort "No Jump Burpee" exercise.
tDCS Targeting the Primary Motor Cortex (M1)
EXPERIMENTALParticipants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the primary motor cortex (M1). The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of M1 stimulation on performance during a maximal effort "No Jump Burpee" exercise.
SHAM tDCS
SHAM COMPARATORParticipants in this arm will receive a sham tDCS session, which simulates the experience of tDCS without actual stimulation. This arm serves as a control to ensure the blinding of participants and evaluators.
Interventions
The anodic electrode will be placed on the left DLPFC (area F3) and the cathode on the right orbitofrontal cortex (area Fp2). Participants will receive 20 minutes of tDCS at 2 mA while seated.
The anodes will be placed over C3 and C4 (according to EEG 10-20 system), and the cathodes over the ipsilateral shoulders. Participants will receive 20 minutes of tDCS at 2 mA while seated.
The electrodes will be placed as in the other conditions, but the stimulation will be switched off after 30 seconds, providing an initial stinging sensation without continuous stimulation.
Eligibility Criteria
You may qualify if:
- Healthy subject.
- No use of any ergogenic substance.
- Participants must be recreationally active, defined as engaging in moderate physical activity at least 3 times per week for the past 6 months
You may not qualify if:
- Any contraindications to transcranial Direct Current Stimulation, such as metallic implants in the head, active implanted medical devices (e.g., pacemakers), or skin conditions affecting the scalp.
- Current or recent (within the past 6 months) substance abuse, including alcohol or recreational drugs.
- Musculoskeletal injury within the past 6 weeks.
- Lower extremity pain above 3 or more according to numeric pain scale.
- History of epilepsy or convulsive crisis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic University of Murcia
Guadalupe, Murcia, 30107, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- To ensure a double-blind design, the researcher who administered the tDCS was not present during the physical measurements, and the evaluator responsible for the physical measurements was unaware of the type of tDCS received by the participant. In this way, participants and evaluators remained blinded to the treatment administered.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 25, 2024
Study Start
January 6, 2024
Primary Completion
March 8, 2024
Study Completion
April 15, 2024
Last Updated
June 25, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share